Leptivia®
INDICATION: Obesity
Leptivia® is a new safe anti-obesity drug product repurposed from existing safe drug molecule.
Discover Leptivia®
Overview
Leptivia® is designed to provide weight loss through satiety and appetite suppression.
Phase
Leptivia® CR is currently in Phase I clinical trial.
US Market ($B USD)
The estimated market for Leptivia® in the United States is $0.85 Billion USD.
Global Market ($B USD)
The estimated market for Leptivia® globally is $1.2 Billion USD.